Patents by Inventor Zachary L. Watson

Zachary L. Watson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS
    Publication number: 20220380808
    Abstract: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
    Type: Application
    Filed: May 6, 2022
    Publication date: December 1, 2022
    Applicants: University of Florida Research Foundation, Incorporated, Board of Supervisors of Louisiana State University & Agricultural & Mechanical College
    Inventors: David C. Bloom, Alfred S. Lewin, Donna M. Newmann, Zachary L. Watson, Sonal Sanjeev Tuli, Gregory Scott Schultz
  • Method for delivering RNA to neurons to treat herpes infections
    Patent number: 11351273
    Abstract: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: June 7, 2022
    Assignees: Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College, University of Florida Research Foundation, Incorporated
    Inventors: David C. Bloom, Alfred S. Lewin, Donna M. Neumann, Zachary L. Watson, Sonal Sanjeev Tuli, Gregory Scott Schultz
  • METHOD FOR DELIVERING RNA TO NEURONS TO TREAT HERPES INFECTIONS
    Publication number: 20190231902
    Abstract: Aspects of the application relate to methods and compositions for delivering therapeutic nucleic acids to neural cells or tissue in a subject. Additional aspects of the application relate to therapeutic nucleic acids, for example therapeutic ribozymes, that are useful for inhibiting viral reactivation in a subject.
    Type: Application
    Filed: June 21, 2017
    Publication date: August 1, 2019
    Applicants: University of Florida Research Foundation, Incorporated, Board of Supervisors of Louisiana State University & Agricultural & Mechanical College
    Inventors: David C. Bloom, Alfred S. Lewin, Donna M. Neumann, Zachary L. Watson, Sonal Sanjeev Tuli, Gregory Scott Schultz